Back to Search
EDGAR LERMA, M.D.
M.D.
Nephrology Physician
NPI: 1841279981IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
036097893(IL)
Education
OTHER
Class of 1991
Research & Publications (20)
Low activation of Insulin-like Growth Factor 1-Receptor (IGF1R) is associated with local recurrence in early breast carcinoma.
PMID 18683043·Breast Cancer Res Treat·2009
8-other
Triple negative breast carcinomas: similarities and differences with basal like carcinomas.
PMID 19620842·Appl Immunohistochem Mol Morphol·2009
6-review
Localized amyloidosis of the breast associated with invasive lobular carcinoma.
PMID 18796554·Br J Radiol·2008
5-case
Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.
PMID 18679714·Virchows Arch·2008
8-other
Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
PMID 17873908·Oncogene·2008
8-other
Prognostic significance of the Fas-receptor/Fas-ligand system in cervical squamous cell carcinoma.
PMID 18000680·Virchows Arch·2008
8-other
[Mixed transitional cell and small cell carcinoma of the bladder with metastases with neuroendocrine histology only. Case report and bibliography review].
PMID 17601310·Arch Esp Urol·2007
5-case
Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.
PMID 17885670·Mod Pathol·2007
8-other
Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).
PMID 17885672·Mod Pathol·2007
8-other
Expression profiles associated with aggressive behavior in Merkel cell carcinoma.
PMID 17115023·Mod Pathol·2007
4-observational
Rituximab is effective for extensive steroid-refractory chronic graft-vs.-host-disease.
PMID 17454609·Leuk Lymphoma·2007
5-case
Durable responses in chronic myeloid leukemia patients maintained with lower doses of imatinib mesylate after achieving molecular remission.
PMID 17576558·Ann Hematol·2007
5-case
Novel compounds with antiproliferative activity against imatinib-resistant cell lines.
PMID 17267662·Mol Cancer Ther·2007
8-other
Radiologic evaluation of breast disorders related to pregnancy and lactation.
PMID 18180221·Radiographics·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3358 W 95TH ST
EVERGREEN PARK, IL 60805 - Phone
- (708) 952-3040
Quick Facts
- NPI
- 1841279981
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile